Total (N=100) | FASH-positive (n=27) | FASH-negative (n=73) | P value | |
Demographic characteristics | ||||
Gender | ||||
Male | 48 (48) | 12 (44) | 36 (49) | 0.82 |
Female | 52 (52) | 15 (55) | 37 (51) | |
Age | ||||
18–30 | 34 (34) | 6 (22) | 28 (38) | 0.26 |
31–40 | 44 (44) | 12 (44) | 32 (44) | |
41–50 | 14 (14) | 6 (22) | 8 (11) | |
>50 | 8 (8) | 3 (11) | 5 (7) | |
Address | ||||
Yirol Town | 36 (36) | 14 (52) | 22 (30) | 0.272 |
Yirol East | 35 (35) | 8 (30) | 27 (37) | |
Yirol West | 22 (22) | 4 (15) | 18 (25) | |
Other | 7 (7) | 1 (4) | 6 (8) | |
Setting | ||||
Inpatient | 58 (58) | 19 (70) | 39 (53) | 0.17 |
Outpatient | 42 (42) | 8 (30) | 34 (47) | |
Clinical characteristics | ||||
Body mass index (kg/m2) | ||||
Low <18 | 83 (89) | 20 (74) | 63 (86) | 1 |
Normal 18–25 | 9 (10) | 2 (7) | 7 (10) | |
High >25 | 1 (1) | 0 (0) | 1 (1) | |
CD4 | ||||
0.2 x109/L | 57 (57) | 22 (81) | 35 (48) | 0.003 |
WHO HIV stage | ||||
I | 13 (13) | 0 (0) | 13 (18) | 0.001 |
II | 30 (30) | 5 (18) | 24 (33) | |
III | 50 (50) | 17 (63) | 33 (45) | |
IV | 7 (7) | 5 (18) | 2 (3) | |
Previous antiretroviral treatment | ||||
Yes | 3 (3) | 2 (7) | 1 (1) | 0.177 |
No | 97 (97) | 25 (93) | 72 (99) | |
Previous TB treatment | ||||
Yes | 10 (10) | 7 (26) | 3 (4) | 0.003 |
No | 90 (90) | 20 (74) | 70 (96) | |
TB prophylaxis | ||||
Yes | 23 (23) | 10 (37) | 13 (18) | 0.059 |
No | 77 (77) | 17 (63) | 60 (82) |
FASH, Focused Assessment with Sonography in HIV-associated tuberculosis; TB, tuberculosis.